Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past hour
Any time
Past 24 hours
Past 7 days
Past 30 days
Most recent
Best match
8m
Despite low obesity rate, Mass. has the third-highest increase in weight-loss drug prescriptions nationwide. Why?
About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent ...
11m
Will Medicare End Ozempic Maker Novo Nordisk's Obesity Drug Boom?
Just how much Medicare price negotiations will negatively impact Novo Nordisk, though, depends on what the final negotiated ...
58m
The race for the next Ozempic is on
Two recent disappointing clinical trials of highly-anticipated weight-loss drugs have made it clear that it is too early to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Los Angeles wildfire updates
California fires: How to help
Set to leave DOGE
Federal workers office return
To pull out of Paris accord
Houston airports closed
Milley's portrait taken down
Today in history: 1976
National championship win
Waltz resigns from House
Vows to rename Denali
NC Rep. Joe John resigns
Capitol riot: 1,500 pardoned
Acting defense secretary
FBI acting chief retires
Agrees to deal w/ Blue Jays?
Laken Riley Act passed
Aid trucks enter Gaza
Rolling out a video tab
Bengals hire Scott Peters
US, Canada lift poultry ban
Tanzania: Marburg outbreak
Houthis to limit attacks
Hands-free tech probe
Tice's mother visits Syria
Vote to authorize strike
Bitcoin hits new record
Women’s rights activist dies
CBP One app shut down
Popular topics
# Novo Nordisk
Related topics
Trump
Medicare
Greenland
Ozempic
United States
Feedback